Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB11 | O95342 | 5/20 | 0.84 |
| ▸ | TBXA2R | P21731 | 3/20 | 0.84 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.84 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.84 |
| ▸ | SLCO2B1 | O94956 | 2/20 | 0.84 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.84 |
| ▸ | SLCO1A2 | P46721 | 2/20 | 0.84 |
| ▸ | SLCO1B3 | Q9NPD5 | 2/20 | 0.84 |
| ▸ | SLCO1B1 | Q9Y6L6 | 2/20 | 0.84 |
| ▸ | MAPT | P10636 | 4/20 | 0.67 |
| ▸ | ABCC4 | O15439 | 4/20 | 0.67 |
| ▸ | ABCC2 | Q92887 | 4/20 | 0.67 |
| ▸ | GAA | P10253 | 3/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.67 |
| ▸ | ABCC3 | O15438 | 3/20 | 0.67 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.67 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.67 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.67 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.67 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL437936 | 1.00 | ABCB11 (0.84) | ABCB11TBXA2RCHRM1PTGS1SLCO2B1 | |
| SCHEMBL22553370 | 1.00 | ABCB11 (0.84) | ABCB11TBXA2RCHRM1PTGS1SLCO2B1 | |
| SCHEMBL16509411 | 1.00 | ABCB11 (0.84) | ABCB11TBXA2RCHRM1PTGS1SLCO2B1 | |
| SCHEMBL18573042 | 1.00 | ABCB11 (0.84) | ABCB11TBXA2RCHRM1PTGS1SLCO2B1 | |
| SCHEMBL30825668 | 1.00 | ABCB11 (0.84) | ABCB11TBXA2RCHRM1PTGS1SLCO2B1 | |
| SCHEMBL31171049 | 1.00 | ABCB11 (0.84) | ABCB11TBXA2RCHRM1PTGS1SLCO2B1 | |
| SCHEMBL16509382 | 0.94 | ABCB11 (0.74) | ABCB11TBXA2RCHRM1PTGS1SLCO2B1 | |
| Rifamide SCHEMBL1650471 | 0.93 | ABCB11 (0.80) | ABCB11TBXA2RCHRM1PTGS1SLCO2B1 | |
| Rifamide SCHEMBL49237 | 0.93 | ABCB11 (0.80) | ABCB11TBXA2RCHRM1PTGS1SLCO2B1 | |
| Rifamide SCHEMBL49236 | 0.93 | ABCB11 (0.80) | ABCB11TBXA2RCHRM1PTGS1SLCO2B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 755 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260102392-A1 | PROPHYLACTIC OR THERAPEUTIC DRUG FOR NEURODEGENERATIVE DISEASES | MEDILABO RFP INC (JP) | 2026-04-16 | — | — | US | claimed |
| US-12521387-B2 | Prophylactic or therapeutic drug for neurodegenerative diseases | MEDILABO RFP, INC. (JP) | 2026-01-13 | — | — | US | claimed |
| CN-120079435-A | Iron single-atom catalyst for high-efficiency directional conversion of rifamycin B to O and application thereof | 浙江大学 | 2025-06-03 | — | — | CN | claimed |
| CN-119023845-A | HPLC method for rapidly and simultaneously separating and measuring rifamycin SV, rifamycin S and rifamycin B in fermentation broth | 神舟生物科技有限责任公司 | 2024-11-26 | — | — | CN | claimed |
| EP-4438039-A2 | ORAL RIFAMYCIN SV COMPOSITIONS | Cosmo Technologies Ltd. (IE) | 2024-10-02 | — | — | EP | claimed |
| EP-3706724-B1 | ORAL RIFAMYCIN SV COMPOSITIONS | COSMO TECHNOLOGIES LTD (IE) | 2024-09-11 | — | — | EP | claimed |
| US-20240139178-A1 | METHOD FOR MANUFACTURING COMPOSITION FOR COMPOSITION FOR INCREASING COGNITIVE FUNCTION | AMYLOID SOLUTION INC. (KR) | 2024-05-02 | — | — | US | claimed |
| CN-117447486-A | Preparation method of rifaximin intermediate rifamycin O | 扬州市三药制药有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-117230131-A | Fermentation method and fermentation medium of rifamycin | 浙江昌海制药有限公司 | 2023-12-15 | — | — | CN | claimed |
| EP-3650024-B1 | PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION COMPRISING RIFAMPICINS FOR TREATING DEMENTIA | MEDILABO RFP INC (JP) | 2023-10-25 | — | — | EP | claimed |
| EP-0980438-A1 | BETAINES AS ADJUDVANTS TO SUSCEPTIBILITY TESTING AND ANTIMICROBIAL THERAPY | Integrated Research Technology, LLC (US) | 2000-02-23 | — | — | EP | claimed |
| US-5985560-A | INSERTION PLASMID INTO DNA | LAL RUP (IN) | 1999-11-16 | — | — | US | claimed |
| WO-1998050576-A1 | BETAINES AS ADJUVANTS TO SUSCEPTIBILITY TESTING AND ANTIMICROBIAL THERAPY | INTEGRATED RESEARCH TECHNOLOGY, LLC (US) | 1998-11-12 | — | — | WO | claimed |
| EP-0877087-A1 | Cloning vectors for Amycolatopsis sp. and a process for the preparation thereof | The Secretary, Department of Biotechnology (IN) | 1998-11-11 | — | — | EP | claimed |
| EP-0046270-B1 | NOVEL DERIVATIVES OF BIO-AFFECTING PHENOLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | INTERx RESEARCH CORPORATION (US) | 1986-05-21 | — | — | EP | claimed |
| US-4431735-A | FERMENTATION OF HUMICOLA OR MONOCILLIUM | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 1984-02-14 | — | — | US | claimed |
| US-4409209-A | POTENTIATION OF ANTIBIOTICS | CIBA-GEIGY CORPORATION (US) | 1983-10-11 | — | — | US | claimed |
| US-4402877-A | DESORPTION | THE DOW CHEMICAL COMPANY (US) | 1983-09-06 | — | — | US | claimed |
| EP-0046270-A1 | Novel derivatives of bio-affecting phenolic compounds and pharmaceutical composition containing them | INTERx RESEARCH CORPORATION (US) | 1982-02-24 | — | — | EP | claimed |
| US-4267274-A | AND NUTRIENT MEDIUM CONTAINING A CARBON SOURCE, A NITROGEN SOURCE AND MINERAL SALTS | GRUPPO LEPETIT S.P.A. (IT) | 1981-05-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240139178-A1 | METHOD FOR MANUFACTURING COMPOSITION FOR COMPOSITION FOR INCREASING COGNITIVE FUNCTION | PSEN2, PSEN1, NEFM | ABCB11 4667/4885TBXA2R 4353/4885CHRM1 399/4885 |
| US-20260102392-A1 | PROPHYLACTIC OR THERAPEUTIC DRUG FOR NEURODEGENERATIVE DISEASES | MAPT, SNCA, FUS | ABCB11 488/4885TBXA2R 4680/4885CHRM1 2788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.